StevenRSchusterMD

PubMed

• A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
  Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Ami...> ;Cancer Research Communications. 2023 Jun 1
• 7 citations
  Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage sm...
  Chao Li, Lowell L. Hart, Taofeek K. Owonikoko, Raid Aljumaily, Caio Max Sao Pedro Rocha Lima, Paul Conkling, Roy Timothy Webb, Robert M. Jotte, Steven R. Schuster, Wil...> ;Cancer Chemotherapy and Pharmacology. 2021 Feb 17
• 98 citations
  Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
  Amanda Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey Sc...> ;Blood Advances. 2019 Oct 22
• 7 citations
  Effect of Group Dynamics–Based Exercise Versus Personal Training in Breast Cancer Survivors
  Heather J. Leach, Kelley R. Covington, Corrine Voss, Kelli A LeBreton, Samantha M. Harden, Steven R. Schuster> ;Oncology Nursing Forum. 2019 Mar 1
• 13 citations
  Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma
  K. Martin Kortuem, Kaitlyn E. Zidich, Steven R. Schuster, Meaghan L. Khan, Victor H Jimenez-Zepeda, Joseph R. Mikhael, Rafael Fonseca, A. Keith Stewart> ;Clinical Lymphoma, Myeloma & Leukemia. 2014 Aug 1
• 80 citations
  The clinical significance of cereblon expression in multiple myeloma
  Steven R. Schuster, K. Martin Kortuem, Yuan Xiao Zhu, Esteban Braggio, Chang Xin Shi, Laura Ann Bruins, Jessica Schmidt, Greg J. Ahmann, Shaji Kumar, S. Vincent Rajkum...> ;Leukemia Research. 2014 Jan 1
• A surprising cause of masses in the chest
  Chad Cherington, Steven R. Schuster, Madappa N. Kundranda, Riccardo Valdez, Ruben A. Mesa, Donald W. Northfelt> ;American Journal of Hematology. 2013 Jun 1
• Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
  Steven R. Schuster, Barbara A. Pockaj, Mary R. Bothe, Paru S. David, Donald W. Northfelt> ;Journal of Personalized Medicine. 2012 Sep 10
• 39 citations
  Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with...
  Anthony R. Mato, Jakub Svoboda, Tatyana Feldman, Tania Zielonka, Harry Agress, David Panush, Mitchell Miller, Patrick Toth, Paul M. Lizotte, Sunita D. Nasta, Stuart L....> ;Cancer. 2012 Jul 15
• 266 citations
  Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.
  Joseph R. Mikhael, Steven R. Schuster, Victor H Jimenez-Zepeda, Nancy Bello, Jacy Spong, Craig B. Reeder, A. Keith Stewart, P. Leif Bergsagel, Rafael Fonseca> ;Blood. 2012 May 10
• The definition of IgM multiple myeloma.
  Schuster, S.R., Rajkumar, S.V., Dispenzieri, A., Morice, W., Aspitia, A.M., Ansell, S., Kyle, R., Mikhael, J.> ;Am J Hematol. 2011-08-01
• Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen.
  Nazha A, Cook R, Vogl DT, Mangan PA, Gardler M, Hummel K, Cunningham K, Luger SM, Porter DL, Schuster S, O'Doherty U, Siegel D, Stadtmauer EA> ;Bone Marrow Transplant.. 2011-01-01
• 54 citations
  IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia
  Steven R. Schuster, S V Rajkumar, Angela Dispenzieri, William G. Morice, Alvaro Moreno Aspitia, Stephen M. Ansell, Robert A. Kyle, Joseph R. Mikhael> ;American Journal of Hematology. 2010 Nov 1
• 12 citations
  Relationship between the cardiometabolic syndrome and obstructive sleep apnea.
  Steven R. Schuster, Maher Tabba, Pradeep Sahota> ;Journal of the Cardiometabolic Syndrome. 2006 Jun 1
• A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.
  Porter DL, Levine BL, Bunin N, Stadtmauer EA, Luger SM, Goldstein S, Loren A, Phillips J, Nasta S, Perl A, Schuster S, Tsai D, Sohal A, Veloso E, Emerson S, June CH> ;Blood. 2006-02-15
• Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
  Loren AW, Luger SM, Stadtmauer EA, Tsai DE, Schuster S, Nasta SD, Goldstein SC, Perl A, Orloff G, Oliver JC, Green J, Emerson SG, Porter DL> ;Bone Marrow Transplant.. 2005-05-01
• Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation.
  Mathias C, Mick R, Grupp S, Duffy K, Harris F, Laport G, Stadtmauer E, Luger S, Schuster S, Wasik MA, Porter DL> ;J. Hematother. Stem Cell Res.. 2000-06-01
• Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy.
  Moore HC, Mick R, Solin LJ, Sickles C, Mangan PA, Luger SM, Fox KR, Schuchter LM, Loh E, Porter DL, Schuster S, Buzby GP, Glatstein E, Silberstein LE, Stadtmauer EA> ;Ann. Oncol.. 1999-08-01
• Join now to see all